RMD-1205

N/A

Report date: 2026/02/11 20:01:36

Base Information

Drug NameRMD-1205
Drug Alias NameRMD-1205RMD1205
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSarcopeniaMuscular Atrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRemedium Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesRemedium Bio Inc
Inactive CompaniesN/A
Active IndicationsSarcopeniaMuscular Atrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A